首页> 外文期刊>American journal of medical genetics, Part A >TSC2 c.1864C > T Variant Aassociated with Mild Cases of Tuberous Sclerosis Complex
【24h】

TSC2 c.1864C > T Variant Aassociated with Mild Cases of Tuberous Sclerosis Complex

机译:TSC2 C.1864C> T变体与细菌硬化复合体的轻度病例相关

获取原文
获取原文并翻译 | 示例
           

摘要

Tuberous sclerosis complex (TSC) is an autosomal dominantly inherited disorder with variable expressivity associated with hamartomatous tumors, abnormalities of the skin, and neurologic problems including seizures, intellectual disability, and autism. TSC is caused by pathogenic variants in either TSC1 or TSC2. In general, TSC2 pathogenic variants are associated with a more severe phenotype than TSC1 pathogenic variants. Here, we report a pathogenic TSC2 variant, c.1864C>T, p.(Arg622Trp), associated with a mild phenotype, with most carriers meeting fewer than two major clinical diagnostic criteria for TSC. This finding has significant implications for counseling patients regarding prognosis. More patient data are required before changing the surveillance recommendations for patients with the reported variant. However, consideration should be given to tailoring surveillance recommendations for all pathogenic TSC1 and TSC2 variants with documented milder clinical sequelae. (C) 2017 Wiley Periodicals, Inc.
机译:肺结核综合复合体(TSC)是一种常染色体培养的遗传紊乱,可变性与海绵状肿瘤相关,皮肤异常,以及包括癫痫发作,智力残疾和自闭症的神经系统问题。 TSC是由TSC1或TSC2中的致病变体引起的。通常,TSC2致病变体与比TSC1病原变体更严重的表型相关联。在这里,我们报告了一种致病性TSC2变体C.1864C> T,p。(Arg622TRP),与轻度表型相关的,大多数载波会议少于TSC的主要临床诊断标准。这一发现对咨询患者的预后具有重大影响。在改变报告的变体患者的监测建议之前需要更多患者数据。然而,应考虑使用记录较高的较高型临床后遗症的所有致病性TSC1和TSC2变体的调查建议。 (c)2017 Wiley期刊,Inc。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号